Global Plant-Based Vaccines Market
Pharmaceuticals

Global Insights: Plant-Based Vaccines Market Expected to Surpass $2.72 Billion by 2029

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Plant-Based Vaccines Industry?

In recent times, the plant-based vaccines market has experienced robust growth. The market size, which stood at $1.66 billion in 2024, is projected to increase to $1.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. This significant growth during the historical period can be linked to issues related to traditional vaccine production, the demand for reasonably priced vaccine production, the advent of plant molecular farming, decreased allergenic potential, and the use of synthetic biology.

The market for plant-based vaccines is predicted to experience swift expansion in the upcoming years. The market value is set to ascend to “$2.72 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the growth during the forecasted period include preparations for pandemics, enhancements in global health security, the broadening scope of vaccine usage, and the adoption of such technology by the pharmaceutical industry. Over the forecast period, key emerging trends include advancements in technology related to plant biotechnology, boosting environmental sustainability, incorporation of artificial intelligence, and the integration of machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Forces Are Driving The Growth Of The Plant-Based Vaccines Industry?

The rampant spread of infectious diseases is anticipated to boost the expansion of the plant-based vaccine market in the future. Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. Plant-based vaccines, used in both conventional and modern medicine for various diseases including infectious ones, can produce secure, efficient, stable, and reasonably costed preventative measures, vaccines, and drugs. For instance, the Global Tuberculosis Report provided by the World Health Organization, a global health institution based in Switzerland, reported in October 2022 that the worldwide occurrence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 people. Southeast Asia accounted for 45% of TB cases, making it the hardest hit, followed by Africa at 23%. As a result, the widespread occurrence of infectious diseases is fueling the plant-based vaccine market’s growth.

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

What Trends Are Currently Influencing Growth In The Plant-Based Vaccines Market?

In the plant-based vaccine market, there is a growing trend towards product innovation. To keep their market position secure, prominent companies in this sector are concentrating on the creation of novel products. As an example, Medicago Inc., a biopharmaceutical firm from Canada, in conjunction with GSK PLC, a pharmaceutical and biotechnology firm from the UK, announced in February 2022 that Health Canada had sanctioned their COVID-19 vaccine, COVIFENZ. This vaccine, COVIFENZ, is the first of its kind, being a plant-based recombinant adjuvant vaccine that employs virus-like particles [VLP]. This is used specifically for the treatment of COVID-19 sufferers. The technology utilised by COVIFENZ is the COVID-19-like particle (CoVLP), with the vaccine consisting of recombinant spike (S) glycoproteins produced as virus-like particles (VLPs).

Who Are The Primary Players Operating Across The Global Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Offers The Most Growth Potential For The Plant-Based Vaccines Market Through 2029?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model